bluebird bio Inc (NASDAQ:BLUE)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - BLUE

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - BLUE

  • Market Cap$3.558bn
  • SymbolNASDAQ:BLUE
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS09609G1004

Company Profile

bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.bluebird bio Inc is a clinical-stage biotechnology company which develops gene therapies for severe genetic and rare diseases and in the field of T cell-based immunotherapy.

Latest BLUE news

Currently there for this company. Visit our news hub for other news .